Literature DB >> 24839947

Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma.

Li Jiang1, Yoriko Yamashita, Shan-Hwu Chew, Shinya Akatsuka, Shun Ukai, Shenqi Wang, Hirotaka Nagai, Yasumasa Okazaki, Takashi Takahashi, Shinya Toyokuni.   

Abstract

Due to the formerly widespread use of asbestos, malignant mesothelioma (MM) is increasingly frequent worldwide. MM is classified into epithelioid (EM), sarcomatoid (SM), and biphasic subtypes. SM is less common than EM but is recognized as the most aggressive type of MM, and these patients have a poor prognosis. To identify genes responsible for the aggressiveness of SM, we induced EM and SM in rats, using asbestos, and compared their transcriptomes. Based on the results, we focused on connective tissue growth factor (Ctgf), whose expression was significantly increased in SM compared with EM; EM itself exhibited an increased expression of Ctgf compared with normal mesothelium. Particularly in SM, Ctgf was a major regulator of MM proliferation and invasion through activation of the β-catenin-TCF-LEF signalling pathway, which is autocrine and formed a positive feedback loop via LRP6 as a receptor for secreted Ctgf. High Ctgf expression also played a role in the epithelial-mesenchymal transition in MM. Furthermore, Ctgf is a novel serum biomarker for both early diagnosis and determining the MM prognosis in rats. These data link Ctgf to SM through the LRP6-GSK3β-β-catenin-TCF-Ctgf autocrine axis and suggest Ctgf as a therapeutic target.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  connective tissue growth factor; mesothelioma; sarcomatoid mesothelioma; serum marker; β-catenin

Mesh:

Substances:

Year:  2014        PMID: 24839947     DOI: 10.1002/path.4377

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.

Authors:  Amélie Ménard; Nour Abou Nader; Adrien Levasseur; Guillaume St-Jean; Marie Le Gad- Le Roy; Derek Boerboom; Marie-Odile Benoit-Biancamano; Alexandre Boyer
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

2.  Blocking CCN2 preferentially inhibits osteoclastogenesis induced by repetitive high force bone loading.

Authors:  Mary F Barbe; Mamta Amin; Anne Gingery; Alex G Lambi; Steven N Popoff
Journal:  Connect Tissue Res       Date:  2020-07-20       Impact factor: 3.417

3.  Dual preventive benefits of iron elimination by desferal in asbestos-induced mesothelial carcinogenesis.

Authors:  Li Jiang; Shan-Hwu Chew; Kosuke Nakamura; Yuuki Ohara; Shinya Akatsuka; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2016-06-13       Impact factor: 6.716

Review 4.  Environmental carcinogenesis - 100th anniversary of creating cancer.

Authors:  Misa Imai; Okio Hino
Journal:  Cancer Sci       Date:  2015-10-21       Impact factor: 6.716

Review 5.  Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.

Authors:  Yoshitaka Sekido
Journal:  Cancers (Basel)       Date:  2018-03-22       Impact factor: 6.639

Review 6.  Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma.

Authors:  Francesca Napoli; Angela Listì; Vanessa Zambelli; Gianluca Witel; Paolo Bironzo; Mauro Papotti; Marco Volante; Giorgio Scagliotti; Luisella Righi
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

7.  Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis.

Authors:  Yue Wang; Yasumasa Okazaki; Lei Shi; Hiro Kohda; Minoru Tanaka; Kentaro Taki; Tomoki Nishioka; Tasuku Hirayama; Hideko Nagasawa; Yoriko Yamashita; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2016-02-18       Impact factor: 6.716

8.  A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.

Authors:  Steven C Kao; Michaela B Kirschner; Wendy A Cooper; Thang Tran; Sjaak Burgers; Casey Wright; Tiny Korse; Daan van den Broek; James Edelman; Michael Vallely; Brian McCaughan; Nick Pavlakis; Stephen Clarke; Mark P Molloy; Nico van Zandwijk; Glen Reid
Journal:  Br J Cancer       Date:  2016-02-18       Impact factor: 7.640

9.  Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.

Authors:  Shenqi Wang; Li Jiang; Yipeng Han; Shan Hwu Chew; Yuuki Ohara; Shinya Akatsuka; Liang Weng; Koji Kawaguchi; Takayuki Fukui; Yoshitaka Sekido; Kohei Yokoi; Shinya Toyokuni
Journal:  Oncotarget       Date:  2016-10-25

10.  Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.

Authors:  Yuuki Ohara; Shan Hwu Chew; Nobuaki Misawa; Shenqi Wang; Daiki Somiya; Kae Nakamura; Hiroaki Kajiyama; Fumitaka Kikkawa; Yuta Tsuyuki; Li Jiang; Kyoko Yamashita; Yoshitaka Sekido; Kenneth E Lipson; Shinya Toyokuni
Journal:  Oncotarget       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.